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httpcense.Abstract Introduction: Medical thoracoscopy increases the diagnostic yield in patients with non-
diagnosed pleural effusion when thoracocentesis and closed pleural biopsy (CPB) are non-diagnos-
tic. Chest ultrasound (US) is a very useful imaging method for pleural diseases and the technique of
ultra sound-guided cutting biopsy with a tru-cut needle has been well described.
Aim of the work: The aim of this work was to diagnose exudative pleural effusion using ultra-
sound guided versus medical thoracoscopic pleural biopsy.
Subjects and methods: Forty patients with, non-diagnosed exudative pleural effusion admitted to
the chest department, Alexandria university hospital, were enrolled after obtaining informed con-
sents. All patients were subjected to; full history taking, thorough clinical examination, laboratory
investigations including prothrombin activity and INR, biochemical, pathological and microbiolog-
ical evaluation of the pleural aspirate and radiological evaluation. Then the patients were divided
(randomly) into 2 groups each containing 20 patients. Pleural biopsies were performed using med-
ical rigid thoracoscopy on group 1 and ultrasound guided tru-cut pleural biopsy on group 2.
Results: The mean age in-group I was 55.0 ± 13.05 years and in-group II was 52.60 ±
17.77 years. There was no statistically signiﬁcant difference between the two groups regarding24474317.
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608 E.E. Mohamed et al.age, sex, smoking, marital status and past medical conditions. There was no statistically signiﬁcant
difference between the two groups regarding radiological ﬁndings. There was no statistically signif-
icant difference between the two groups regarding the pleural ﬂuid analysis. There was no statisti-
cally signiﬁcant difference between the two groups regarding the gross pleural ﬁndings. In group II
non- speciﬁc pleurisy was found in 5 (25.0%) patients (by thoracoscopy 1 of them was ﬁnally diag-
nosed as metastatic deposits from adenocarcinoma of unknown primary, one was conﬁrmed to be
tuberculous pleurisy and the remaining 3 cases were conﬁrmed to be non- speciﬁc pleurisy). As
regards complications in-group I, local wound infection occurred in 1 (5.0%) patient, and empyema
occurred in 1 (5.0%) patient. In-group II, local wound infection occurred in 1 (5.0%) patient, and
empyema occurred in 1 (5.0%) patient.
Conclusion: It is better to use thoracoscopy in cases of undiagnosed exudative pleural effusion
presented with a sufﬁcient amount of pleural ﬂuid to avoid lung injury while inserting the trocar.
Whereas, ultrasound guided tru-cut pleural biopsy may be used in cases of undiagnosed exudative
pleural effusion presented with thickened pleura but with an insufﬁcient amount of pleural ﬂuid.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Introduction
Although pleural effusion is a common disorder among pa-
tients presenting with respiratory symptoms, there is limited
evidence on the accuracy and reliability of symptoms and
signs for the diagnosis of pleural effusion [1]. While diagnos-
tic procedures are available to explore most of the body cav-
ities for diagnosis and treatment, examination of the pleural
cavity remains difﬁcult, mainly because the negative pressure
in the pleural cavity makes direct examination impossible
without collapsing the lung. The ability to diagnose pleural
and pulmonary disease by conventional techniques, such as
blind pleural and lung biopsy, cytology of bronchial wash-
ings and brushing and radiologic techniques or cultures is
limited and ﬂexible ﬁberoptic pleuroscopy permits direct
examination of the pleura, the superﬁcial portions of the
lung, and many other intrathoracic structures. It provides
excellent results without complications. Flexible ﬁberoptic
pleuroscopy is not only safe, but also promises to yield more
accurate biopsy specimens than conventional blind diagnostic
techniques [2].
The differential diagnosis of exudative pleural effusion is
often a lengthy process. As regards pleural malignancies, the
diagnostic yield of closed pleural biopsy (CPB) is only 50–
60% overall, and 20% in malignant mesothelioma (MM).
Contrary to thoracocentesis and percutaneous CPB, thoracos-
copy permits biopsy with direct visualization. Thoracoscopy is
commonly performed after one or two thoracocenteses and at
least one non-diagnostic CPB. Thoracoscopy can be per-
formed by a pulmonologist under local/regional anesthesia
(medical thoracoscopy) or by a thoracic surgeon under general
anesthesia (video-assisted thoracic surgery). The former is pri-
marily used for differential diagnosis of pleural disease and
pleurodesis, whereas the latter permits minimally invasive tho-
racic surgery. Several studies suggest that medical thoracos-
copy increases the diagnostic yield in patients with non-
diagnosed pleural effusion when thoracocentesis and CPB
are non-diagnostic [1,3].
Blind percutaneous pleural biopsy has traditionally been
performed to investigate the etiology of exudative pleural effu-
sion in which the initial thoracocentesis has been non-diagnos-
tic. In view of the increasing use of image-guided andthoracoscopic pleural biopsies, the role of ultrasound guided
pleural biopsy in the investigation of pleural effusion is
increasing [4].
Chest ultrasound (US) is a very useful imaging method for
pleural diseases and the technique of US-guided cutting biopsy
with a tru-cut needle has been well described [5,6].Aim of the work
The aim of this work was to diagnose exudative pleural effu-
sion using ultrasound guided versus medical thoracoscopic
pleural biopsy.Subjects and methods
Study population and subjects
Forty patients with, non-diagnosed exudative pleural effusion
admitted to the chest department, Alexandria university hospi-
tal, were enrolled after obtaining informed consents. All pa-
tients had a prothrombin activity >70%.
Study measurements
All patients were subjected to the following:
 Full history taking including: age, sex, smoking index and
history of other diseases.
 Thorough clinical examination including: general examina-
tion and local chest examination.
 Laboratory investigations including: prothrombin activity
and INR.
 Biochemical, pathological and microbiological evaluation
of the pleural aspirate.
 Radiological evaluation was carried out by:
- Plain X-ray chest postero-anterior and lateral views.
- Computed tomographic (CT) scan of the chest with
focus made on the side and amount of effusion, pleural
lesions, underlying lung lesions, metastasis and any other
lesions that could be detected.
Then the patients were divided (randomly) into 2 groups
each containing 20 patients. Pleural biopsies were performed
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guided tru-cut pleural biopsy on group 2.
Medical rigid thoracoscopy (group I)
Thoracoscopic examination was done using rigid thoracoscopy
[(Karl Storz; Tuttlingen, Germany] and its equipment and vid-
eoscopy unit (camera [Karl Storz Endoskope Telecam Pal
20211020], light source [Henke-Sass Wolf Gmbh d-7200 Tut-
tingen)], TV box connected to the PC and television (LCD
3200).
The procedure was performed in an endoscopy suite espe-
cially equipped for the procedure, in the chest department, fac-
ulty of medicine, Alexandria University.
The patient was positioned lying down in a lateral decubi-
tus position with the involved side facing upwards. The pa-
tient’s blood pressure, pulse rate, intravenous line and
oxygen saturation were monitored continuously using a porta-
ble monitor connected totally with all its leads and its pulse
oximetry to the patient. Supplemental oxygen was given to
the patient to maintain oxygen saturation. The entire lateral
chest wall was scrubbed with iodopovidone. The patient was
then subjected to local anesthesia and conscious sedation;
15–20 ml lidocaine 2% for local anesthesia, and conscious
sedation was achieved by midazolam 15 mg/ml.
After raising a 2 cm subcutaneous wheal and anesthetizing
the skin, subcutaneous tissues, muscle planes, rib periosteum
and parietal pleura by about 20 cc of 2% lidocaine, a 2 cm
transverse skin incision was made by a scalpel parallel to the
rib along the intercostal space chosen for the trocar and obtu-
rator of the medical rigid thoracoscope insertion in the wheal.
Blunt dissection of the intercostal tissues was performed by
spreading straight Kelly clamp (or artery clamp) both parallel
and perpendicular to the underlying muscles which were sepa-
rated and the parietal pleura was gently palpated by the index
ﬁnger and was penetrated by the Kelly clamp. The rigid trocar
and obturator of the medical rigid thoracoscope were inserted
through the incision, down the preformed tract, penetrating
the pleural membrane into the pleural cavity.
Once in place, we remove the obturator and insert a suction
tube (20 cm H2O) connected to suction apparatus [HOSPI-
VAC sm350 REF210358] through the trocar to drain any asso-
ciated pleural ﬂuid.
After drainage of the ﬂuid, medical rigid thoracoscope was
introduced through the trocar into the pleural space. The tho-
racoscope was connected to a video camera in order to display
the whole procedure on a monitor (LCD 3200) and can be re-
corded on a CD by TV BOX connected to the PC. Inspection
and full visualization all around the pleural cavity were then
done by the rigid thoracoscope. The parietal pleura including
the costal, diaphragmatic sometimes mediastinal pleura as well
as the visceral pleura was thoroughly examined for any lesions
such as nodules, plaques, adhesions, thickening, mottling or
anthracosis. Multiple forcep biopsies were taken from any sus-
picious gross pathological lesion in the parietal pleura. The vis-
ceral pleura was not biopsied. The biopsies were taken by one
of the rigid forceps made especially for the rigid thoracoscope
as Basket/Crocodile/Straight/Crush which was passed through
the channel of the rigid thoracoscope. The biopsies were then
kept in a sterile bottle ﬁlled with formalin and then these bot-
tles were sent to pathology laboratory for histopathologicalexamination and diagnosis of at least one specimen for micro-
biological investigations (transported in 0.9% saline).
After the procedure, the trocar and thoracoscope were re-
moved and then thoracostomy tube (chest tube 24-Charrie`re)
was inserted and ﬁxed in position to the skin of the chest wall
using zero silk interrupted vertical mattress sutures with purse
string suture far around the chest tube for easy closure of the
skin ﬂap after chest tube removal (cosmetic suture). Well-cared
dressing was applied. The dressing was routinely changed and
inspected daily for the functioning of the chest tube either
working well (oscillating) or obstructed (need to be ﬂushed)
or out of place (need to be re inserted). Plain chest X-ray
and CT chest were done just after the procedure to make sure
that the chest tube was in place. Daily plain X-ray chest was
done to verify that the lung was fully expanded. Then when
full expansion of the lung occurs, pleurodesis was performed
(only in recurrent or malignant cases). The chest tube was ﬁrst
clamped with two clamps and was disconnected from the suc-
tion tube of the draining device. Twenty cubic centimeter of
lidocaine (one percent concentration) was instilled into the
pleural cavity through the chest tube to anesthetize the pleura.
Under the strict aseptic technique, ﬁfty cubic centimeter of
iodopovidone (ten percent concentration) was added to ﬁfty
cubic centimeter of normal saline in a sterile bowl and aspi-
rated into the ﬁfty cubic centimeter Tommy0s syringe. The syr-
inge was attached to the chest tube and the solution was
instilled through the chest tube after both clamps have been re-
moved, then the remaining ﬁfty cubic centimeter of the solu-
tion was instilled in the same manner.
Once all the solution was instilled, the patient was allowed
to take few breaths, with the chest tube unclamped, so that all
the solution could be pulled into the pleural space. The tube
was then clamped and connected to the draining device. Chest
radiograph was done daily to assure full lung re-expansion.
Once this latter was achieved, the chest tube was removed.
After removing the chest tube, a plain chest radiograph was
obtained to check the full expansion of the lung.
Close observation for any complication was carried out and
recorded. The complications were then managed. The most
common, serious and important complication is failure of lung
expansion, which is considered a complication when lung
failed to expand just after the end of the procedure. This was
checked by oscillations of the chest tube and the ﬁrst chest
X-ray P-A view done after the procedure.
Follow up of the patients was carried out radiographically
by plain chest X-ray until removal of the chest tube.
Ultrasound guided tru-cut pleural biopsy (group II)
The sonography was done using Toshiba Just Vision 200 SSA-
320A; Toshiba Medical Systems Corporation, Tochigi-ken,
Japan. The preferred position for the procedure was the sitting
position, with the subject’s arms folded across the chest and sup-
ported by a bedside table. Surveillance of the dorso-lateral tho-
racic wall was performed by means of a standard 3.75 MHz
sector probe. The size of the effusion was documented as
follows: minimal (if the echo-free space was conﬁned to the
costophrenic angle), small (if the space was greater than the
costophrenic angle but still within the range of the area
covered with a 3.75 MHz curvilinear probe), moderate (if the
space was greater than a one-probe range but within a two-probe
610 E.E. Mohamed et al.range and large (if the space was larger than a two-probe range).
The biopsy site was subsequently identiﬁed, with safety being a
main determinant. As a rule, the aspirations and biopsies were
performed in mid-scapular line. For minimal to moderate effu-
sions, the biopsies were taken from the site of maximum effusion
as determined byUS. In case of a large effusion, the puncture site
was chosen to be as low as possible, but not within 25 mm of the
diaphragm. All aspirations and biopsies were performed under
direct US guidance and patients were requested to remain
motionless during the procedures.
Percutaneous ultrasound-guided pleural biopsy was done
with a 14- or 18-gauge cutting needle (Allegiance, Chateaubri-
and, France) or (Temno; Bauer Medical International, Santo
Domingo, Dominican Republic) with the use of a local anes-
thetic. These needles have a 20-mm-long specimen notch on a
central stylet that was manually advanced before application
of the cutting needle so that the needle did not travel any fur-
ther, allowing good control of the needle position. The puncture
site was disinfected and anesthetized by inﬁltration with 2 per-
cent lidocaine. The patient was asked to hold his breath, and the
needle was inserted into the lesion under ultrasound guidance.
Suction was applied while the needle was further advanced to
the required depth. Under the sterile technique and local anes-
thesia, at least four tru-cut needle biopsies (transported in 4%
formalin and at least one specimen for microbiological investi-
gations (transported in 0.9% saline) were obtained.
Special care was taken not to exceed the measured depth of
the lesion. Although aerated lung beyond the lesion was punc-
tured occasionally, the depth of penetration was minimal.
For focal pleural masses, the biopsy needle was advanced
along the maximal diameter of the lesion. For diffuse pleuralTable 1 Comparison between the two studied groups accord-
ing to personal data.
Group I Group II p
Age
Median (min.–max.) 58.0 (21.0–70.0) 58.0 (17.0–83.0) 0.629
Mean ± SD 55.0 ± 13.05 52.60 ± 17.77
Sex
Male 13 (65.0%) 9 (45.0%) 0.204
Female 7 (35.0%) 11 (55.0%)
Marital status
Single 1 (5.0%) 2 (10.0%) 1.000
Married 17 (85.0%) 16 (80.0%)
Widow 2 (10.0%) 2 (10.0%)
Smoking
Non smoking 12 (60.0%) 13 (65.0%) 0.744
Smoking 8 (40.0%) 7 (35.0%)
Pack/year for smokers
Median (min.–max.) 40.0 (15.0–80.0) 50.0 (6.0–90.0) 0.335
Mean ± SD 42.78 ± 20.78 53.71 ± 29.27
Residence
Alexandria 17 (85.0%) 11 (55.0%) 0.100
Behira 3 (15.0%) 7 (35.0%)
Kafr El Sheikh 0 (0.0%) 1 (5.0%)
Matrouh 0 (0.0%) 1 (5.0%)
Past history
HTN 2 (10.0%) 4 (20.0%) 0.503
DM 3 (15.0%) 1 (5.0%)thickening, the cutting needle was advanced along the plane
of maximal pleural thickness to allow the majority of the
biopsy specimen notch to lie within the abnormal pleura.
The patients had at least 4 h of bed rest after the procedure;
routine post biopsy observations (pulse rate, blood pressure,
and respiratory rate) were made. All patients were observed
for at least 4 h prior to discharge, and complications were
noted. Chest radiographs were obtained after the procedure
to exclude pneumothorax.
Results
The mean age in-group I was 55.0 ± 13.05 years and in-group
II was 52.60 ± 17.77 years. In-group I 13 out of 20 patients
(65.0%) were males, while in-group II 9 out of 20 patients
(45.0%) were males. As regards smoking, in-group I 12 pa-
tients (60.0%) were non-smokers while in-group II 13 patients
(65.0%) were non-smokers.
The mean pack-years for smokers in-group I was
42.78 ± 20.78, whereas, it was 53.71 ± 29.27 in-group II.
Hypertension (HTN) was present in 2 patients (10.0%) and
4 patients (20.0%) in the two groups, respectively, whereas,
diabetes mellitus (DM) was present in 3 patients (15.0%)
and 1 patient (5.0%) in the two groups, respectively.
There was no statistically signiﬁcant difference between the
two groups regarding age, sex, smoking, marital status and
past medical conditions (Table 1).
Radiological ﬁndings
In-group I; right moderate pleural effusion was detected in 7
(35.0%) patients, left moderate pleural effusion was detected
in 3 (15.0%) patients, right massive pleural effusion was de-
tected in 7 (35.0%) patients and left massive pleural effusion
was detected in 3 (15.0%) patients. Encystment was detected
in 2 (10.0%) patients. Thickened pleura was detected in 11
(55.0%) patients. Pleural nodules and soft tissue shadow were
not detected in any patients and malignant lymph nodes
(M.L.N) were enlarged in only 1 (5.0%) patient.
In-group II; right moderate pleural effusion was detected in
6 (30.0%) patients, left moderate pleural effusion was detected
in 6 (30.0%) patients, right massive pleural effusion was de-
tected in 3 (15.0%) patients and left massive pleural effusion
was detected in 5 (25.0%) patients. Encystment was not de-
tected in any patients. Thickened pleura was detected in 12Table 2 Comparison between the two studied groups accord-
ing to radiological ﬁndings (chest X-ray and CT).
Group I Group II p
Radiological ﬁndings
Pleural eﬀusion
Right moderate 7 (35.0%) 6 (30.0%) 0.394
Left moderate 3 (15.0%) 6 (30.0%)
Right massive 7 (35.0%) 3 (15.0%)
Left massive 3 (15.0%) 5 (25.0)
Encystment 2 (10.0%) 0 (0.0%) 0.487
Thickened pleura 11 (55.0%) 12 (60.0%) 0.749
Pleural nodules 0 (0.0%) 2 (10.0%) 0.487
Soft tissue shadow 0 (0.0%) 2 (10.0%) 0.487
M.L.N 1 (5.0%) 1 (5.0%) 1.000
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detected in 2 (10.0%) patients and M.L.N were enlarged in
only 1 (5.0%) patient.
There was no statistically signiﬁcant difference between the
two groups regarding radiological ﬁndings (Table 2).
Pleural ﬂuid analysis
In-group I; the mean value of pleural total protein was
4.37 ± 0.51 mg/dl, the mean of pleural albumin was
3.34 ± 0.30 mg/dl, and the mean of pleural lactic acid dehy-
drogenase (LDH) was 572.65 ± 463.27 mg/dl. The mean of
pleural total white blood cells (WBCs) was
3635.20 ± 1982.27/mm3, with negative pleural culture and
sensitivity, negative for malignant cells and negative pleural
ﬂuid examination for acid-fast bacilli (AFB). The mean ofTable 3 Comparision between the two studied groups according to
Group I
Pleural total protein
Median (min.–max.) 4.20 (3.70–6.0)
Mean ± SD 4.37 ± 0.51
Pleural albumin
Median (min.–max.) 3.35 (2.90–4.0)
Mean ± SD 3.34 ± 0.30
Pleural LDH
Median (min.–max.) 432.5 (256–2222)
Mean ± SD 572.65 ± 463.27
Pleural total WBCs
Median (min.–max.) 3150 (1240–7000)
Mean ± SD 3635.20 ± 1982.2
N%
Median (min.–max.) 52.50 (16.0–80.0)
Mean ± SD 50.06 ± 24.39
L%
Median (min.–max.) 42.50 (16.0–77.0)
Mean ± SD 43.10 ± 23.82
M%
Median (min.–max.) 3.0 (1.0–25.0)
Mean ± SD 4.55 ± 5.32
B%
Median (min.–max.) 1.40 (0.60–7.50)
Mean ± SD 1.72 ± 1.56
E%
Median (min.–max.) 0.50 (0.10–1.50)
Mean ± SD 0.58 ± 0.38
Pleural ﬂuid culture and sensitivity 0 (0.0%)
Pleural ﬂuid for AFB 0 (0.0%)
Pleural ﬂuid cytology 0 (0.0%)
Pleural/serum protein ratio
Median (min.–max.) 63.95 (55.80–80.0
Mean ± SD 65.27 ± 5.86
Pleural/serum LDH ratio
Median (min.–max.) 81.35 (73.10–95.2
Mean ± SD 82.04 ± 5.36
Pleural-serum albumin gradient
Median (min.–max.) 0.40 (0.20–0.90)
Mean ± SD 0.50 ± 0.22pleural/serum protein ratio was 65.27 ± 5.86, pleural/serum
LDH ratio was 82.04 ± 5.36 and the mean of pleural-serum
albumin gradient was 0.50 ± 0.22 · 103/lL.
In-group II; the mean value of pleural total protein was
4.48 ± 0.49 mg/dl, the mean of pleural albumin was
3.36 ± 0.34 mg/dl and the mean of pleural LDH was
451.75 ± 75.0 mg/dl. The mean of pleural total WBCs was
3812.90 ± 1303.75/mm3, with negative pleural culture and
sensitivity, pleural ﬂuid was positive for malignant cells in
only one case and negative pleural ﬂuid examination for
AFB. The mean of pleural/serum protein ratio was
63.95 ± 6.22, pleural/serum LDH ratio was 84.19 ± 3.82
and the mean of pleural-serum albumin gradient was
0.4 ± 0.12.
There was no statistically signiﬁcant difference between the
two groups regarding the pleural ﬂuid analysis (Table 3).pleural ﬂuid analysis.
Group II p
4.35 (3.80–5.20) 0.468
4.48 ± 0.49
3.30 (2.90 – 4.0) 0.808
3.36 ± 0.34
480 (310–590) 0.704
451.75 ± 75.0
3560 (1050–6541) 0.441
7 3812.90 ± 1303.75
44.50 (10.0–67.0) 0.244
44.70 ± 19.52
45.0 (26.0–82.0) 0.198
49.20 ± 20.08
3.0 (1.0–8.0) 0.691
3.38 ± 1.98
1.25 (0.20–3.0) 0.881
1.50 ± 0.85
0.90 (0.20–6.0) 0.066
1.23 ± 1.30
0 (0.0%) –
0 (0.0%) –
1 (5.0%) 1.000
) 60.95 (55.10–74.30) 0.492
63.95 ± 6.22
0) 84.30 (77.50–92.30) 0.152
84.19 ± 3.82
0.45 (0.20–0.70) 0.640
0.4 ± 0.12
Table 4 Comparison between the two studied groups accord-
ing to gross ﬁndings (thoracoscopic in Group I or by
ultrasound in Group II).
Group I Group II p
Amount of drained pleural ﬂuid
Median (min.–max.) 3.25 (0.75–8.0) – –
Mean ± SD 3.84 ± 1.81 –
Side
Right 14 (70.0%) 10 (50.0%) 0.197
Left 6 (30.0%) 10 (50.0%)
Parietal pleura 20 (100.0%) 20 (100.0%) –
Visceral pleura 20 (100.0%) 20 (100.0%) –
Costal pleura 20 (100.0%) 20 (100.0%) –
Diaphragmatic pleura 6 (30.0%) 4 (20.0%) 0.716
Diﬀuse thickening 4 (20.0%) 7 (35.0%) 0.480
Nodules 18 (90.0%) 15 (75.0%) 0.204
Plaques 2 (10.0%) 2 (10.0%) 1.000
Adhesions 6 (30.0%) 11 (55.0%) 0.110
Others
Anthracosis 5 (25.0%) – –
Mottling 1 (5.0%) –
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In-group I; the mean amount of drained pleural ﬂuid was
3.84 ± 1.81 L, the right side was affected in 14 (70.0%) pa-
tients, the left side was affected in 6 (30.0%) patients. Parietal
pleura, visceral pleura, and costal pleura were affected in 20
(100.0%) patients whereas diaphragmatic pleura was affected
only in 6 (30.0%) patients. Diffuse thickening was detected
in 4 (20.0%) patients. Nodules were detected in 18 (90.0%) pa-
tients. Plaques were detected in 2 (10.0%) patients. AdhesionsTable 5 Comparison between the two studied groups according to
Grou
SCLC 0 (0.0
LCC 3 (15
Malignant mesothelioma of known primary 1 (5.0
Breast 3 (15
Thyroid 0 (0.0
Endometrium 1 (5.0
Renal 1 (5.0
Colon 1 (5.0
Intestine 1 (5.0
Of unknown primary 4 (20
Inﬂammatory
Tuberculous pleurisy 4 (20
Non-speciﬁc pleurisy 1 (5.0
Complications
1-Local wound infection 1 (5.0
2-Empyema 1 (5.0
Management of complications
Dressing, ABC 1 (5.0
ICT, antibiotics 1 (5.0
Outcome (cure) 2 (10
* Statistically signiﬁcant.were detected in 6 (30.0%) patients. Anthracosis was detected
in 5 (25.0%) patients, and mottling was detected in only 1
(5.0%) patient.
In-group II; the right side was affected in 10 (50.0%) pa-
tients; the left side was affected in 10 (50.0%) patients. Parietal
pleura, visceral pleura and costal pleura were affected in 20
(100.0%) patients whereas diaphragmatic pleura was affected
only in 4 (20.0%) patients. Diffuse thickening was detected
in 7 (35.0%) patients. Nodules were detected in 15 (75.0%) pa-
tients. Plaques were detected in 2 (10.0%) patients and adhe-
sions were detected in 11 (55.0%) patients.
There was no statistically signiﬁcant difference between the
two groups regarding the gross pleural ﬁndings (Table 4).
Histopathological diagnosis and complications
In-group I; the histopathological diagnosis was large cell carci-
noma (LCC) in 3 (15.0%) patients and malignant mesotheli-
oma in 1 (5.0%) patient. Metastatic deposits from known
primary were found in 7 (35.0%) patients (from the breast in
3 (15.0%) patients, from the endometrium in 1 (5.0%) patient,
from the kidney in 1 (5.0%) patient, from the colon in 1 (5.0%)
patient and from the Intestine in 1 (5.0%) patient). Metastatic
deposits from adenocarcinoma of unknown primary were
found in 4 (20.0%) patients. Tuberculous pleurisy was found
in 4 (20.0%) patients and non- speciﬁc pleurisy was found in
1 (5.0%) patient.
In-group II; the histopathological diagnosis was small cell
lung cancer (SCLC) in 1 (5.0%) patient, LCC in 2 (10.0%) pa-
tients and malignant mesothelioma in 2 (10.0%) patients. Met-
astatic deposits from known primary were found in 8 (40.0%)
patients (from the breast in 3 (15.0%) patients, from the thy-
roid in 1 (5.0%) patient, from the endometrium in 1 (5.0%) pa-
tient, from the kidney in 1 (5.0%) patient, from the colon in 1histopathological diagnosis, and complications.
p I Group II p
%) 1 (5.0%) 1.000
.0%) 2 (10.0%) 0.673
%) 2 (10.0%) 0.487
.0%) 3 (15.0%) 1.000
%) 1 (5.0%) 0.487
%) 1 (5.0%) 0.605
%) 1 (5.0) 1.000
%) 1 (5.0%) 1.000
%) 1 (5.0%) 1.000
.0%) 1 (5.0%) 0.342
.0%) 1 (5.0%) 0.342
%) 5 (25.0%) 0.041*
%) 1 (0.0%) 1.000
%) 1 (5.0%) 1.000
%) 1 (5.0%)
%) 1 (5.0%)
.0%) 2 (10.0%)
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Metastatic deposits from adenocarcinoma of unknown pri-
mary were found in 1 (5.0%) patient. Tuberculous pleurisy
was found in 1 (5.0%) patient and non- speciﬁc pleurisy was
found in 5 (25.0%) patients (by thoracoscopy 1 of them was
ﬁnally diagnosed as metastatic deposits from adenocarcinoma
of unknown primary, one was conﬁrmed to be tuberculous
pleurisy and the remaining 3 cases were conﬁrmed to be
non-speciﬁc pleurisy).
As regards complications in-group I, local wound infection
occurred in 1 (5.0%) patient, and empyema occurred in 1
(5.0%) patient.
As regards complications in-group II, local wound infection
occurred in 1 (5.0%) patient, and empyema occurred in 1
(5.0%) patient (Table 5).
Discussion
Medical thoracoscopy can be done under general or local anes-
thesia as stated by the European Respiratory Society (ERS)
depending on the indication and severity of illness, as well as
on the experience of the physician and institutional biases [1,7].
Although the ultrasound guided tru-cut pleural biopsy may
appear to be unsuitable for pleural biopsy because there is no
facility for aspiration of ﬂuid to conﬁrm entry into the pleural
space, it is particularly useful in the presence of thickened
pleura, which is found in tuberculosis and certain malignant
processes [6,8].
In the present study, we placed the studied patient on his lat-
eral decubitus position with the affected side facing up and no
increase in dyspnea was noticed in any patient. This was similar
to previous studies, on the body positional effect on gas ex-
change in unilateral pleural effusion, which reported improved
dyspnea, oxygenation and pulmonary function tests on lateral
decubitus position with the affected side facing up [1,9,10].
In the current study, we preferred to use local anesthesia
with conscious sedation in-group I patients and local anesthe-
sia only in-group II, as it is safer, lacks the complications of
general anesthesia and general condition of some patients with
massive effusion may not allow the use of general anesthesia.
Similarly, most previous studies performed thoracoscopy un-
der local anesthesia and conscious sedation [7,11–15]. In con-
trast, some previous studies performed thoracoscopy under
general anesthesia [16,17]. We recognize that general anesthe-
sia would markedly facilitate all the intervention; however, it
would increase the patient’s risk.
In-group II unfortunately, it was not possible to drain any
amount of pleural ﬂuid associated with the pleural pathology
whereas in-group I, drainage of several liters (up to 8 L in
one case) of pleural ﬂuid was done at once with no risk of
re-expansion pulmonary edema. This was possible by immedi-
ate equilibration of pressure secondary to direct entrance of air
through the cannula into the pleural space from around the
draining catheter during the procedure. In a previous study
by De Campos et al. [18] who detected 12 patients (2.2%)
developed re-expansion pulmonary edema, the total ﬂuid
drained during thoracoscopy in those patients was always
>3000 ml (range, 3200–5000 ml). Prolonged duration of col-
lapse and rapid re-expansion of the lung because of application
of negative pressure were assumed to be the underlying causes
of re-expansion pulmonary edema in this study. Theyrecommended performing one or two therapeutic thoracente-
ses before thoracoscopy, with the drainage of at least
1500 ml at each procedure for patients with large pleural effu-
sions and to evaluate lung expansion. Other studies suggest
that large pleural effusions should be drained in a controlled
fashion avoiding evacuation of more than 1–1.5 L at one time
or slowed to about 500 ml/h, and aspiration discontinued if the
patient develops chest discomfort, persistent cough, or vasova-
gal symptoms [19,20].
Some of our patients experienced sharp transient pain while
the biopsies were taken. The administration of local intrapleu-
ral lidocaine resolved this nuisance. Other patients experienced
little or no discomfort when the parietal pleura was touched.
This could be due to decreased pleural sensation in most pa-
tients with chronic pleurisy (malignant or benign) [21]. Consis-
tent with our observation Oldenburg et al. [22], reported
transient sharp pain in all their cases during parietal pleural
biopsy. This was greatly relieved by pre-treatment of the site
of the biopsy with lidocaine.
In the present study, we found that thoracoscopic appear-
ances were mostly conﬁrmed histologically, as the presence
of nodules mostly indicates malignancy, while diffuse thicken-
ing, adhesions and plaques suggest tuberculous or other
inﬂammatory pleural affections.
This was in agreement with Enk and Viskum [23], who per-
formed 556 thoracoscopies and reported that in patients with
gross pleural abnormality, thoracoscopic appearances were
quiet diagnostic. Boutin et al. [24] performed rigid thoracos-
copy in 188 cases of idiopathic pleural effusion and reported
congestion, ﬁne granulations and pleural thickening suggesting
non-speciﬁc inﬂammation in 12 (6.5%) cases and nodules or
masses suggestive of malignancy in 92 (49%) patients. George
et al. [12] performed rigid thoracoscopy in 12 cases of idio-
pathic pleural effusion; they demonstrated pleural nodules in
4 cases and adhesions in 8 cases.
Histopathological diagnosis was matched with the gross
appearance in the last 3 studies [12,23,24]. However, we deﬁ-
nitely need biopsies and histopathological diagnosis as pleural
nodules were found also in some cases of tuberculous pleural
affection. Other studies reported that thoracosopic appear-
ances were not reliable, and that it was danger to rely upon
inspection of the pleura alone without biopsies [22,25–28].
Similarly, sonographic appearances of group II were mostly
conﬁrmed histologically, as the presence of nodules mostly
indicates malignancy, while diffuse thickening suggests tuber-
culous or other inﬂammatory pleural affections.
The sensitivity of diagnostic thoracoscopy in our study was
100%, signifying a high diagnostic yield of medical thoraco-
scope. The diagnostic sensitivity in previous thoracoscopic
studies varied from 66% to 100% [13,21,29–31]. In-group II,
tru-cut biopsies yielded pleural tissue in 100% of patients
and the diagnostic sensitivity was 90% which was much higher
than a previous study by Chang et al. [6] who reported that;
Tru-cut biopsies yielded pleural tissue in 78.7% of patients en-
rolled into this study, and it had diagnostic sensitivity of
65.2% for pleural TB and 66.7% for malignancy. This was
nearly similar to a previous similar study by Rosie et al. [32],
who reported that the overall accuracy of percutaneous image
guided biopsy was about 91%, which means that thoracoscop-
ic biopsies may be superior to sonographic guided tru-cut
biopsies.
614 E.E. Mohamed et al.In-group I, fortunately we were able to obtain biopsies
from all the studied patients. In contrast to our results Franc-
ois et al. [11], performed diagnostic thoracoscopy in 149 cases
and reported failure to reach the diagnosis in 10 cases (6.8%).
They explained this failure by the presence of extensive pleural
adhesions that limited the access to the pleural cavity. Also,
Sophie et al. [29], described failure to obtain biopsies in 3 case
out of 50 cases (6%) during medical thoracoscopy due to either
extensive pleural adhesions or lack of any pleural abnormality
during thoracoscopy.
Differences between our ﬁndings and those of others [21,29]
can be attributed to the lack of accurate deﬁnition of the term
excessive adhesions. It remains a subjective description and an-
other could report what could seem excessive to one as some
adhesions. In-group II, tru-cut biopsies yielded pleural tissue
in 100% of patients which was much higher than a previous
study by Chang BD et al. [6] who reported that tru-cut biopsies
yielded pleural tissue in 78.7% of patients enrolled onto this
study, which may be attributed to the recent advances in the
ultrasound ﬁeld.
In the present study, in-group I, 1 patient was diagnosed as
non-speciﬁc pleurisy. He received non-speciﬁc antibiotic ther-
apy and the follow up for 6 months revealed full cure with
no recurrent effusion. The incidence of non-speciﬁc pleurisy
in previous studies performing thoracoscopy in undiagnosed
pleural effusion varied from 0% [16] up to 38.2% [11]. Hansen
et al. [30] reported 45 out of 147 (31%) cases of chronic non-
speciﬁc pleurisy however, 12 patients were proved malignant
later on. Similarly, Davidson et al. [21] reported 8 out of 29
(27.59%) cases of chronic non-speciﬁc pleurisy however, 4
cases were proved to be malignant later on. Both authors did
not mention how the ﬁnal diagnosis was assured [21,30].
In-group II, non-speciﬁc pleurisy was the ﬁnal diagnosis in
5 (25.0%) patients (by thoracoscopy 1 of them was ﬁnally
diagnosed as metastatic deposits from adenocarcinoma of un-
known primary, the second one was conﬁrmed to be tubercu-
lous pleurisy and the remaining 3 cases were conﬁrmed to be
non-speciﬁc pleurisy), so it is essential either to follow up cases
with non-speciﬁc pleurisy or to conﬁrm the diagnosis by
thoracoscopy.
In-group I, complications were encountered in 2 (10%) pa-
tients. The incidence of complications in the previous studies
was variable. The reported incidence of complications follow-
ing rigid thoracoscopy varied from 1.8%, [25] up to 20% [16].
Similarly in-group II, complications were encountered in 2
(10%) patients. with no pneumothorax. This differs from a
previous study by Benamore et al. [33] who reported that the
rate of new pneumothorax detected by chest radiography
was 4.7%.
The incidence of complications in the previous similar stud-
ies was minimal. The reported incidence of complications fol-
lowing image guided tru-cut pleural biopsy was about 3%
[32,33] the higher rate of complications in our study may be
attributed to fewer number of cases (only 20 patients in each
group) in comparison with previous similar studies.
During the past decade, thoracoscopic biopsy has become
a widely accepted means of diagnosis if ﬁndings from pleural
ﬂuid cytologic examination and blind pleural biopsy are
non-diagnostic. The advantages are its sensitivity of 91–
98% for the diagnosis of pleural malignancy [34,35] and
its potential therapeutic beneﬁt, such as enabling talc pleu-
rodesis. Thoracoscopy has the disadvantage of requiringgeneral anesthesia or sedation, requiring chest tube drainage
and inpatient stay, having the potential of failure due to
adhesions preventing pneumothorax, being substantially
more expensive than image-guided biopsy, and having a
higher complication rate [36,37].
Some authors have also shown that it is safe to biopsy the
pleura with the tru-cut needle under ultrasound guidance in
situations in which the pleura is thickened and when the pleu-
ral effusion is small in amount or loculated [6,32].
In conclusion, it is better to use thoracoscopy in cases of
undiagnosed exudative pleural effusion presented with a sufﬁ-
cient amount of pleural ﬂuid to avoid lung injury while insert-
ing the trocar whereas, ultra sound guided tru-cut pleural
biopsy may be used in cases of undiagnosed exudative pleural
effusion presented with thickened pleura but with an insufﬁ-
cient amount of pleural ﬂuid.
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